Market Overview:

The Biopsy Devices Market size is estimated to reach $2.71 Billion by 2030, growing at a CAGR of 4% during the forecast period 2024-2030, according to a recent report published by IndustryARC, titled, “Biopsy Devices Market – By Product (Needle-Based Biopsy Instruments {Core Biopsy Devices, Aspiration Biopsy Devices, Vacuum-Assisted Biopsy Devices}, Procedure Trays, Localization Wires, Others), By Guidance Technique (Ultrasound-Guided, Stereotactic-Guided, MRI-Guided, CT-Guided, Others), By End-User (Hospitals, Academic and Research Institutes, Diagnostic and Imaging Centers), By Application (Breast Biopsy, Lung Biopsy, Colorectal Biopsy, Prostate Biopsy, Others), By Geography - Global Opportunity Analysis & Industry Forecast, 2024-2030”
Opportunities driven by government initiatives and Technological advancements are expected to create growth opportunities in the market during forecast period.

North America Dominated the Market in 2023:

North America accounted for the largest share of 38% of the Biopsy Devices Market in 2023. In May 2023, Argon Medical Devices launched the SuperCore Advantage, a new semi-automatic biopsy instrument for the U.S. market. These innovations not only cater to the clinical needs but also drive market growth, solidifying North America's position as the preeminent market for biopsy devices.

Biopsy Devices Market: Key Takeaways

Increasing Cancer Rates & Early Detection:

The growing prevalence of cancer, largely influenced by aging populations and lifestyle shifts, has significantly increased the demand for biopsy devices. As cancer incidence rises, early detection has become a priority, prompting healthcare providers to adopt more frequent and precise diagnostic techniques. Technological advancements in biopsy devices, including minimally invasive methods and real-time imaging, have improved the safety and effectiveness of these procedures, making them more attractive to both patients and physicians. This surge in demand highlights the critical role of biopsy devices in early cancer detection and management.

Personalized Medicine & Innovation-Driven Market:

The healthcare industry’s move toward personalized medicine has intensified the need for accurate and targeted diagnostic tools, propelling demand for advanced biopsy devices. To meet this need, manufacturers are focusing on innovation, developing cutting-edge, user-friendly biopsy devices that meet diverse clinical requirements. These advancements foster competition in the market, driving further improvements and ensuring higher adoption rates in medical settings. As personalized treatment becomes more integral to healthcare, biopsy devices will continue to be essential for precise diagnosis and tailored treatment planning. 

For More Queries About "Biopsy Devices Market " @ https://www.industryarc.com/pdfdownload.php?id=501286

Scope of the Report: 

Report Metric

Details

Base Year Considered

2023

Forecast Period

2024–2030

CAGR

4%

Market Size in 2030

$2.71 Billion

Segments Covered

By Product, By Guidance Technique, By End-User, By Application

Geographies Covered

North America (U.S., Canada and Mexico), Europe (Germany, France, UK, Italy, Spain, Russia and the Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Australia & New Zealand and the Rest of Asia-Pacific), South America (Brazil, Argentina, Chile, Colombia and Rest of South America), Rest of the World (Middle East and Africa).

Key Market Players

1.  Argon Medical Devices, Inc.

2.  Becton, Dickinson and Company

3.  GE Healthcare

4.  B. Braun

5.  Boston Scientific Corporation

6.  Hologic, Inc.

7.  Cardinal Health, Inc.

8.  Cook Group Incorporated

9.  Danaher Corporation (Mammotome)

10.  Fujifilm Holdings Corporation



Recent Developments:

In May 2023, Argon Medical Devices launched the SuperCore Advantage, a new semi-automatic biopsy instrument for the U.S. market.
In May 2022, Terumo India joined forces with Argon Medical to bring a wider range of medical solutions to the Indian market. By combining their strengths, they addressed the increasing need for advanced tools in biopsies, deep vein thrombosis treatments, and other procedures.
In April 2023, GE Healthcare unveiled the bkActiv system, an advanced ultrasound imaging solution designed for surgical applications. This system empowers surgeons by providing real-time imaging and enhancing their decision-making during surgical procedures.

Biopsy Devices Market: Competitive Landscape

Key companies profiled in the Biopsy Devices Market are Argon Medical Devices, Inc., Becton, Dickinson and Company, GE Healthcare, B. Braun, Boston Scientific Corporation, Hologic, Inc., Cardinal Health, Inc., Cook Group Incorporated, Danaher Corporation (Mammotome), Fujifilm Holdings Corporation, and Others.

About IndustryARC™:

IndustryARC primarily focuses on Market Research and Consulting Services specific to Cutting Edge Technologies and Newer Application segments of the market. The company’s Custom Research Services are designed to provide insights into the constant flux in the global demand-supply gap of markets. 

IndustryARC’s goal is to provide the right information required by the stakeholder at the right point in time, in a format that assists an intelligent and informed decision-making process.


Contact Us:

Mr. Venkat Reddy

IndustryARC

Email: [email protected]

USA: (+1) 518-282-4727